← Eichor
Study identifier: NCT07238465 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Exploring Sympathetic Nervous System Function in Individuals With Down Syndrome

Condition: Down Syndrome · Autonomic Dysfunction  ·  Sponsor: University of Colorado, Denver

PhasePhase 3
Planned participants200
Who can joinAll sexes, 18 Years to 50 Years
Healthy volunteersYes

About this study

Down syndrome (DS), the most common genetic cause of intellectual disability, is associated with widespread organ dysfunction, including abnormalities in the autonomic nervous system (ANS). The ANS regulates critical functions such as heart rate (HR) and blood pressure (BP), both essential for maintaining homeostasis and supporting physical activity. Individuals with DS often exhibit blunted HR responses to exercise-typically \~30 beats per minute below expected levels-suggesting reduced sympathetic nervous system (SNS) activity. The SNS governs rapid changes in HR and BP during stress by releasing catecholamines: epinephrine (from the adrenal medulla) and norepinephrine (from sympathetic nerve endings). Despite its importance, SNS function has not been comprehensively assessed among individuals with DS. This study addresses a critical knowledge gap by evaluating SNS responses to physiological stressors in individuals with DS. The investigators will measure beat-to-beat HR and BP, along with plasma catecholamine levels, in response to sympathetic activation, comparing individuals with DS to age- and sex-matched controls. Understanding the mechanisms of SNS dysfunction in DS is vital, as it likely underlies reduced exercise capacity and contributes to broader clinical challenges. These insights may guide targeted interventions to improve cardiovascular function, physical capacity, and overall quality of life in this understudied population.

This description comes directly from the study's public registry record.

Talk to the study team

Sara R Sherman, PhD  ·  303-724-0598  ·  sara.r.sherman@cuanschutz.edu

Constance Brecl  ·  constance.brecl@cuanschutz.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical CampusAurora, Colorado, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07238465